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Abstract.	
	
Polypous	 rhinosinusitis	 remains	 one	 of	 the	 major	 problems	 of	 modern	
otorhinolaryngology,	its	prevalence	in	general	population	reaches	4%.	There	is	a	
wide	range	of	variants	of	clinical	course	and	a	different	response	 to	 traditional	
methods	 of	 treatment,	 however	 all	 these	 cases	 are	 diagnosed	 as	 “polypous	
rhinosinusitis”.	 It	 suggests	 the	heterogeneity	 of	 a	 group	 of	patients	diagnosed	
with	 “polypous	 rhinosinusitis”	 and	 the	 need	 for	 a	 detailed	 study	 of	 various	
clinical	variants	of	nasal	polyposis,	i.e.	clinical	phenotypes	of	the	disease.	
The	 objective	of	 the	 research	was	 to	assess	 clinical	 features	of	 chronic	
polypous	 rhinosinusitis	 depending	 on	 trigger	 of	 the	 disease	 as	 well	 as	 to	
determine	clinical	phenotypes	of	nasal	polyposis.	
Materials	 and	methods.	The	article	presents	 the	 results	of	 clinical	and	
anamnestic	investigations,	radiology	examinations	and	laboratory	studies	of	150	
patients	with	various	types	of	polypous	rhinosinusitis.	Patients	were	divided	into	
three	 groups:	 Group	 I	 included	 50	 patients	 with	 aspirin-intolerant	 polyposis;	
Group	 II	 consisted	 of	 50	 patients	 with	 polyposis	 due	 to	 violations	 of	
aerodynamics	of	 the	nasal	breathing;	Group	 III	 included	50	patients	with	 Ig-E-
dependent	(allergic)	polyposis,		
Results.	 The	 research	 revealed	 significant	 differences	 in	 studied	
indicators	 	 between	 different	 clinical	 groups.	 The	 presence	 of	 differences	 in	
gender,	 age,	 severity	 of	 clinical	 symptoms	 and	 the	 character	 of	 pathological	
changes	 allowed	 us	 to	 determine	 the	 most	 common	 clinical	 phenotypes	 of	
polypous	rhinosinusitis.	
Conclusions.	 The	 onset	 of	 the	 disease	 affecting	 primarily	 females	 in	
adulthood,	severity	of	clinical	manifestations,	total	or	subtotal	lesions	of	sinuses	
resulting	 in	 resistance	 to	 traditional	 methods	 of	 treatment	 are	 typical	 for	
patients	with	aspirin-intolerant	polyposis.	The	above	mentioned	phenotypes	are	
considered	 within	 a	 clearly	 defined	 pathology	 and	 allow	 us	 to	 optimize	 the	
diagnostic	process	as	well	as	to	determine	adequate	therapeutic	tactics	for	each	
clinical	case.	
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Problem	statement	and	analysis	of	the	recent	research	
	 Polypous	 rhinosinusitis	 is	 a	 chronic	 inflammatory	 disease	 of	 the	 nasal	 mucosa	 and	
paranasal	sinuses	characterized	by	the	formation	of	polyps.	Epidemiological	and	statistical	studies	
indicate	that	the	prevalence	of	polypous	rhinosinusitis	in	general	population	of	Europe	is	between	
2%	 to	 4%.	 Patients	 with	 polypous	 rhinosinusitis	 account	 for	 5%	 of	 the	 total	 number	 of	 patients	
consulting	ENT	specialists	and	4%	of	patients	visiting	allergologists	[1,	2,	3,	4,	5].	However,	there	are	
other	data	that	the	disease	manifests	itself	in	15-25%	of	patients	with	ENT	diseases	[6].	
Clinically,	 the	 term	 “nasal	polyposis”	involves	all	types	of	nasal	polyps,	found	within	the	
ethmoid	 bone,	 the	 middle	 meatus,	 and	 the	 middle	 turbinate	 which	 appear	 as	 gray-blue	
evaginations.	 	 Larsen	 P.I.	 and	 Stammberger	 H.	 consider	 the	 mucous	 membrane	 of	 the	 middle	
turbinate	 and	 the	 middle	 meatus	 to	 be	 the	 origin	 of	 polyps	 while	 the	 inferior	 turbinate	 has	 no	
tendency	 of	 nasal	 polyp	 formation	 [7,	 8,	 9].	 The	 reasons	 are	 unknown.	 Nowadays	 there	 is	 no	
adequate	definition	of	nasal	polyps,	or	nasal	polyposis.	According	to	Stedman’s	Medical	Dictionary	
(1995)	polyp	is	a	general	descriptive	term	used	with	reference	to	any	mass	of	tissue	that	bulges	or	
projects	outward	or	upward	from	the	normal	surface	level,	thereby	being	macroscopically	visible	as	
a	hemispheroidal,	spheroidal,	or	irregular		 mound-like	 structure	 growing	 from	a	 relatively	broad	
base	or	a	slender	stalk	[10].	It	means	that	any	spherical	outgrowth	of	the	nasal	mucosa	or	paranasal	
sinuses	should	be	considered	as	nasal	polyp.	Some	authors	consider	chronic	sinusitis	and	nasal	
polyposis	 as	 various	 diseases	 of	 the	 mucosa	 [11].	 Nowadays	 there	 is	 a	 consensus	 that	 chronic	
rhinosinusitis	is	a	major	disease	and	nasal	polyposis	is	its	subpopulation	[12].	
Histologically,	 nasal	 polyps	 are	 characterized	 by	 swelling	 and/or	 fibrosis,	 reduced	
vascularization,	 decreased	 number	 of	 glands	 and	 nerve	 endings,	 and	 damaged	 epithelium.	
Histological	 examination	 of	 polyps	 allows	 us	 to	 differentiate	 eosinophilic	 polyps	 constituting	
approximately	65-90%	of	all	cases	 from	neutrophilic	polyps	 [13,	14].	Neutrophil-dominant	polyps	
are	detected	histologically	in	15-20%	of	cases.	Neutrophils	are	associated	with	the	growth	of	polyps	
in	cystic	fibrosis,	Young’s	syndrome,	Kartagener’s	syndrome	and	immotile	cilia	syndrome	 [15-18].	
They	are	usually	connected	with	a	certain	genetic	functional	defect	 in	the	mucociliary	apparatus	
due	to	violations	of	the	rheological	properties	of	nasal	mucous	or	damage	to	the	cilia	of	the	ciliated	
epithelium.	 In	 this	case	chronic	polypous	 rhinosinusitis	 is	 syndromic	 in	nature	with	co-existent	
lesions	of	respiratory	and	other	systems.	
Eosinophilic	 polyps	 received	 their	 name	 due	 to	 the	 presence	 of	 tissue	 eosinophilia	
accompanied	 by	 mononuclear	 cell	 infiltration,	 plasma	 cell	 infiltration,	 and	 T-cell	 infiltration.	
Pathogenetically,	a	large	number	of	tissue	eosinophils	on	the	background	of	their	normal	content	
in	 the	blood	 is	explained	by	 increased	 transendothelial	migration	and	 inhibition	of	programmed	
cell	death	 (apoptosis)	of	 eosinophils	 [19,20].	 Impregnation	and	accumulation	of	plasma	proteins	
(albumin)	is	considered	as	the	link	between	tissue	eosinophilia	and	polyp	growth.	
Over	recent	years	nasal	polyposis	is	considered	as	a	heterogeneous	disease	that	could	fail	
to	 impact	 its	 classifications.	 In	 modern	 otorhinolaryngology,	 there	 are	 many	 different	
classifications	of	polypous	 rhinosinusitis.	 In	particular,	 according	 to	 the	prevalence	of	polypous	
process	 in	 the	nasal	 cavity,	 lesions	 of	 the	paranasal	 sinuses,	 their	 localization	 [3,	 21,	 22,	 27].	 In	
addition	 to	 clinical	 classifications	 there	 are	 also	 clinical	 and	 morphological	 classifications	 of	
polypous	rhinosinusitis.	The	development	of	nasal	polyps	is	classified	into	two	phases:	the	initial	
phase	 is	edematous	or	glandular	and	cystic	one	and	 the	 second	 stage	 is	 fibrous	one.	The	use	of	
topical	corticosteroids	at	the	first	stage	can	cause	regression	of	polyposis,	and	at	the	fibrous	stage	
only	surgical	treatment	is	effective.	[23].	Another	classification	distinguishes	antrochoanal	polyps,	
large	 isolated	 (choanal)	 polyps,	 chronic	 non-eosinophilic	 dominant	 polypous	 rhinosinusitis,	
chronic	 eosinophilic	 dominant	 polypous	 rhinosinusitis	 and	 polyps	 associated	 with	 specific	
conditions	 (fibrous	 cysts,	 malignancy,	 etc.)	 [15-18,	 24].	 A	 significant	 number	 of	 classifications	
indicates	that	despite	the	 large	amount	of	diverse	research	there	 is	no	consensus	on	the	etiology	
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and	pathogenesis	of	polypous	process.	Current	research	proves	quite	convincingly	 that	polypous	
rhinosinusitis	 is	significantly	different	 from	other	 forms	of	chronic	 inflammation	not	only	 in	 the	
pathogenesis,	 morphological	 pattern	 and	 clinical	 course,	 but	 also	 in	 the	 nature	 of	 local	 tissue	
response	 to	 surgery	 and	 medication.	 However,	 all	 researchers	 refer	 polypous	 rhinosinusitis	 to	
diseases	 treatment	 of	 which	 is	 ineffective	 due	 to	 frequent	 relapses.	 Relapses	 of	 polypous	
rhinosinusitis	 after	 surgical	 treatment	 reach	 60-80%.	 20%	 of	 patients	 develop	 recurrent	 nasal	
polyposis	within	1	month	after	surgery,	42%	of	patients	develop	it	a	year	after	surgery,	and	in	81%	
of	patients	recurrent	nasal	polyposis	is	diagnosed	2	years	after	surgery	[2,	3,	4,	5,	13,	26].	
Particular	 attention	 is	 given	 to	 treatment	 of	 polyposis	 in	 comorbidity,	 since	 there	 was	
observed	 that	nasal	polyposis	 is	 often	 associated	with	 severe	diseases	 such	 as	 asthma,	 chronic	
obstructive	pulmonary	disease,	aspirin	 intolerance,	allergy	and	others.	There	 is	a	wide	 range	of	
variants	of	clinical	course	and	a	different	response	to	traditional	methods	of	treatment,	however	
all	these	cases	are	diagnosed	as	“polypous	rhinosinusitis”.	It	suggests	the	heterogeneity	of	a	group	
of	patients	diagnosed	with	 “polypous	 rhinosinusitis”	and	the	need	for	a	detailed	study	of	various	
clinical	variants	of	nasal	polyposis,	i.e.	clinical	phenotypes	of	the	disease.	
The	closest	approach	to	modern	understanding	of	polyposis	phenotypes	was	made	by	S.Z.	
Piskunov	who	described	the	following	clinical	and	pathogenic	variants	of	polypous	rhinosinusitis:	
− related	to	changed	architectonics	of	the	nasal	cavity;	
− allergic	(Ig-E-dependent);	
− fungal	(allergic	fungal	sinusitis);	
− syndromal:	 cystic	 fibrosis,	 Young’s	syndrome,	Kartagener’s	syndrome,	 large	 group	 of	 so-
called	tubulopathies,	or	immotile	cilia	syndrome;	
− polyposis	associated	with	intolerance	to	aspirin	(aspirin	triad).	
However,	 the	 indicated	 types	of	polyposis	are	determined	when	defining	 triggers	of	 the	
disease	that	is	insufficient	for	clinical	practice.	The	identification	of	the	features	of	clinical	course	
of	 each	 polyposis	 form	 is	 relevant	 in	 terms	 of	 allocation	 of	 a	 specific	 patients’	 phenotype.	
Phenotypic	characteristics	are	convenient	 to	use	as	diagnostic	and	prognostic	criteria	 for	various	
ethiopathogenetic	forms	of	polypous	rhinosinusitis.		
The	 objective	 of	 the	 research	 was	 to	 assess	 clinical	 features	 of	 chronic	 polypous	
rhinosinusitis	depending	on	 trigger	of	 the	disease	as	well	as	 to	determine	clinical	phenotypes	of	
nasal	polyposis.	
	
Materials	and	methods	
The	 study	 included	 150	 patients	 diagnosed	 with	 “chronic	 polypous	 rhinosinusitis”	who	
were	 hospitalized	 in	 the	 ENT	 department	 of	 the	 Regional	 Clinical	 Hospital	 within	 2011-2014.	
Patients	were	divided	into	three	groups:	Group	I	included	50	(33.3%)	patients	with	aspirin-intolerant	
polyposis;	Group	II	consisted	of	50	(33.3%)	patients	with	polyposis	due	to	violations	of	aerodynamics	
of	 the	 nasal	 breathing;	 Group	 III	 included	 50	 (33.3%)	 patients	 with	 Ig-E-dependent	 (allergic)	
polyposis.	
Clinical	 peculiarities	 determining	 the	 phenotype	 features	 include	 age-related	 and	
chronological	 aspects	 of	 the	 disease,	 sex-specific	 prevalence	 of	 the	 disease,	 prevalence	 and	
morphological	 characteristics	 of	 inflammation,	 type	 of	 the	 disease	 course,	 the	 efficiency	 of	 its	
treatment	using	the	most	effective	conventional	methods.	
	
Results	and	discussion	
The	moment	of	disease	manifestation	 (diagnosis	of	polypous	rhinosinusitis)	and	disease	
duration	were	determined	according	to	the	patient’s	words	or	date	when	diagnosis	was	made	as	
indicated	 in	his/her	outpatient	medical	record.	At	the	moment	of	making	a	diagnosis	all	patients	
were	divided	into	2	groups	according	to	the	age	classification:	
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Group	1	–	young	people	(17-35	years	old);	
Group	2	-	mature	and	elderly	people	(36-70	years	old).	
Among	patients	of	Group	 I	 -	aspirin-intolerant	polyposis	was	 first	diagnosed	 in	mature	
and	elderly	people	in	most	cases	-	41	(82%)	patients.	The	number	of	patients	in	Group	II	-	polyposis	
due	 to	violations	of	aerodynamics	of	 the	nasal	breathing	 -	was	divided	almost	equally	 -	26	 (52%)	
young	people	versus	24	(48%)	older	people.	Among	patients	of	Group	III	-	Ig-E-dependent	(allergic)	
polyposis	there	were	36	(72%)	young	people.	
Thus,	 the	 incidence	 of	 chronic	 polypous	 rhinosinusitis	 in	 age	 groups	 was	 divided	 very	
unevenly.	 The	 peak	 incidence	 of	 aspirin-intolerant	 polyposis	 compared	 to	 other	 types	 of	
rhinosinusitis	prevailed	in	the	mature	age	group.	It	developed	in	82%	of	people	within	the	age	range	
of	 36-70	 years.	 72%	of	 young	patients	 suffered	 from	 Ig-E-dependent	polyposis.	The	 incidence	of	
polyposis	 due	 to	 violations	 of	 aerodynamics	 of	 the	 nasal	 breathing	 had	 no	 age-dependence,	 as	
patients	were	distributed	evenly	-	52%	of	young	people	versus	48%	of	older	people.		
Gender	 is	one	of	 the	most	 important	criteria	determining	 the	phenotype.	There	was	an	
obvious	 trend	 towards	higher	prevalence	of	polyposis	 in	males	of	Group	 II	 and	Group	 III.	There	
were	32	(64%)	men	in	Group	II	being	28%	more	than	women	-	18	(36%)	and	27	(54%)	men	in	Group	
III.	Among	patients	with	aspirin-intolerant	polyposis,	female	patients	prevailed	-	58%	(29	patients);	
there	 were	 42%	 (21	 patients)	 of	 males,	 respectively.	 These	 data	 are	 significantly	 different	 from	
gender	 differences	 in	 other	 groups	 with	 polyposis,	 where	 the	 incidence	 among	 women	 is	
significantly	less	than	among	men.	
Age	 and	 gender	 indicators	 characterize	 the	 incidence	of	polyposis	 at	 the	 time	of	 initial	
diagnosis.	However,	the	period	of	disease	 in	most	patients	was	probably	significantly	 longer,	and	
visit	to	a	doctor	was	preceded	by	a	latent	period,	long-term	compensation	of	the	symptoms	of	the	
disease,	impaired	nasal	breathing	as	a	result	of	self-medication	in	particular,	or	banal	indifference	
of	patients.	The	duration	of	 the	disease	 is	 important	when	assessing	clinical	peculiarities	of	any	
chronic	processes.	Therefore,	we	studied	the	age	of	onset	depending	on	gender	(Fig.1).	
	
	
Fig.1.	PMH	(past	medical	history)	duration	
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	 It	 is	noteworthy	 that	patients	with	disease	duration	of	more	 than	 three	years	constituted	
the	 largest	part	among	men	and	women.	The	relatively	short	duration	 in	both	sexes	was	almost	
the	same:	up	to	1	year	in	13.95±2.36%	of	males	and	14.29±3.21%	of	females;	31.93±4.27%	of	men	and	
29.77±2.52%	of	women	 reported	 on	 the	 duration	 of	 1-3	 years.	 Within	 the	 range	 of	 3-5	 years	 the	
disease	duration	in	men	was	significantly	higher	than	in	women	–	27.44±3.04%	versus	14.29±3.21%.	
The	difference	in	the	indicators	was	13.15%.	Within	the	range	of	5-10	years	of	disease	duration	the	
indicators	were	aligned:	 indicators	of	men	significantly	reduced	by	11.36%	while	those	of	women	
tended	 to	 increase.	However,	 the	duration	of	 the	disease	of	over	10	years	 in	women	significantly	
dominated	 over	 the	 indicators	 of	 men:	 22.69±3.84%	 versus	 12.56±2.26%.	 The	 difference	 in	 the	
indicators	was	10.13%.	The	indicated	dynamics	may	indicate	a	more	severe	course	of	polyposis	in	
females.	
Clinical	 manifestations	 of	 polyposis	 do	 not	 cause	 special	 difficulty	 in	 its	 detection.	
Common	symptoms	are	difficult	breathing	through	nose,	nasal	discharge	and	presence	of	polyps	
in	the	nasal	cavity.	To	determine	the	duration	of	the	disease	 is	also	not	difficult.	However,	 in	the	
context	 of	 determining	 the	 phenotype,	 the	 relevant	 problem	 is	 to	 diagnose	 the	 extent	 of	 sinus	
lesions.	Therefore,	the	diagnosis	in	all	patients	was	based	on	the	patient’s	complaints	and	history	
taking,	results	of	otorhinolaryngological	and	 routine	X-ray	examination,	as	well	as	 the	 results	of	
nasal	endoscopic	examination,	computed	tomography	of	the	nasal	cavity,	sinuses	and	elements	of	
the	 osteomeatal	 complex.	 According	 to	 the	 results	 of	 examinations	 considering	 ICD-10	
requirements	 patients	 were	 divided	 into	 groups	 depending	 on	 the	 number	 of	 affected	 sinuses.	
People	 with	 a	 lesion	 of	 one	 or	 several	 sinuses	 on	 one	 side	 constituted	 a	 group	 of	 mono-
hemisinusitis,	people	with	bilateral	lesions	(not	of	all	sinuses	were	affected)	constituted	a	group	of	
polysinusitis,	and	people	with	pervasive	lesions	of	the	sinuses	constituted	a	group	of	pansinusitis.	
Among	patients	of	Group	I	-	aspirin-intolerant	polyposis	-	in	most	cases	(84.73%)	pervasive	
lesions	of	the	sinuses	(pansinusitis)	were	diagnosed	and	in	15.27%	of	cases	subtotal	lesions	of	the	
sinuses	(excluding	the	basilar	sinus)	were	detected.	
Among	 patients	 of	 Group	 II	 -	 polyposis	 due	 to	 violations	 of	 aerodynamics	 of	 the	 nasal	
breathing	-	lesions	of	the	sinuses	were	mainly	observed	in	the	form	of	maxilla-ethmoidal	sinusitis	
with	a	slightly	swollen	mucosa	of	other	sinuses	on	the	same	side	being	conventionally	regarded	as	
hemisinusitis.	Among	patients	of	Group	 III	 -	 Ig-E-dependent	 (allergic)	polyposis	 -	 the	number	of	
patients	with	pansinusitis	accounted	for	more	than	half	of	cases	-	63.48%.	In	36.52%	of	patients	of	
this	 group	 multiple	 bilateral	 lesions	 were	 diagnosed.	 The	 represented	 data	 indicated	 the	
unquestionable	 dominance	 of	 multiple	 forms	 of	 sinus	 lesions	 over	 isolated	 ones	 in	 patients	 of	
Group	I	and	Group	III.	This	feature	characterized	aspirin-intolerant	polyposis	and	Ig-E-dependent	
(allergic)	 polyposis	 as	 the	 pathology	 with	 severe	 course.	 The	 severity	 significantly	 affects	 the	
treatment	 outcomes.	 Therefore,	 we	 conducted	 a	 detailed	 study	 of	 the	 course	 of	 the	 disease	 in	
patients	of	these	groups.	
The	distinctive	 feature	of	patients	with	 Ig-E-dependent	 (allergic)	polyposis	was	 the	 fact	
that	 patients	 with	 disease	 duration	 of	 more	 than	 three	 years	 but	 not	 more	 than	 ten	 years	
constituted	 the	 largest	part	 (73.3%).	The	number	of	patients	with	 relatively	short	duration	of	 the	
disease	(3-5	years)	among	patients	with	aspirin-intolerant	polyposis	was	significantly	less	-	41.7%.	
Within	the	range	of	3-5	years	the	duration	of	the	disease	 in	patients	did	not	exceed	19.6%	versus	
57.1%	among	patients	with	Ig-E-dependent	(allergic)	polyposis.	The	difference	in	the	indicators	was	
37.5%.	Within	the	range	of	5-10	years	of	disease	duration	indicators	were	aligned:	in	Ig-E-dependent	
polyposis	 they	 reduced	 by	 22.1%	 and	 in	 aspirin-intolerant	 polyposis	 they	 tended	 to	 increase	 by	
16.2%.	 However,	 disease	 duration	 of	 more	 than	 10	 years	 in	 patients	 with	 aspirin-intolerant	
polyposis	increased	progressively	and	significantly	exceeded	the	indicators	in	patients	with	allergic	
polyposis:	56.4%	versus	12.5%.	The	difference	 in	 the	 indicators	was	43.9%.	The	above-mentioned	
dynamics	 indicated	 a	 more	 severe	 course	 of	 the	 disease	 in	 patients	 with	 aspirin-intolerant	
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polyposis	and	higher	efficiency	of	treatment	of	allergy-dependent	form	of	the	disease.	Since	among	
patients	with	aspirin-intolerant	polyposis	women	prevailed	these	data	correlated	with	peculiarities	
of	the	age	of	onset.	Disease	duration	of	over	10	years	 in	women	significantly	prevailed	 indicators	
in	men:	22.69±3.84%	versus	12.56±	2.26%.	These	data	indicated	the	prevalence	of	severe	forms	of	the	
disease	in	female	population.	
The	disease	of	 long	duration	 (over	10	years)	reflected	the	progressive	course	of	polyposis	
and	was	associated	with	frequent	relapses.	The	vast	majority	of	patients	developed	from	4-5	to	16-
20	and	more	polypotomias.	Frequent	recurrence,	in	turn,	was	an	evidence	of	resistance	to	the	most	
effective	methods	of	treatment	(surgery,	steroids).	These	features	characterized	aspirin-intolerant	
polyposis	as	the	pathology	with	particularly	severe	course	of	the	disease.	
When	analyzing	age-related	and	chronological	aspects	of	chronic	polypous	rhinosinusitis	
there	 was	 found	 that	 the	 peak	 incidence	 among	 patients	 with	 aspirin-intolerant	 polyposis	
prevailed	in	the	mature	age	group.	Within	the	range	of	36-70	years	82.3%	of	patients	were	diagnosed	
with	 the	 disease,	 the	 number	 of	 women	 dominated	 over	 that	 of	 men.	 However,	 taking	 into	
consideration	the	duration	of	the	disease,	the	onset	of	the	disease	probably	occurred	significantly	
earlier	in	the	young	age	group	as	this	group	was	characterized	by	long	duration	of	the	disease.	
72.3%	 of	 young	 patients	 suffered	 from	 Ig-E-dependent	 polyposis.	 The	 incidence	 of	
polyposis	 due	 to	 violations	 of	 aerodynamics	 of	 the	 nasal	 breathing	 had	 no	 age-dependence,	 as	
patients	were	distributed	 evenly	 –	50.87%	of	young	people	versus	49.13%	of	older	people.	Among	
patients	 of	 these	 groups	 the	 number	 of	 men	 prevailed.	 When	 disease	 occurred	 in	 all	 groups	 of	
patients	 its	 clinical	 symptoms	 had	 no	 special	 manifestations	 and	 were	 peculiar	 for	 chronic	
rhinosinusitis.	They	were	often	diagnosed	as	chronic	catarrhal	or	allergic	rhinosinusitis.	
The	predominance	of	patients	with	 long	disease	duration	can	 indicate	the	prevalence	of	
severe	 forms	of	the	disease	as	their	specific	 feature	 is	 low	efficiency	of	treatment	and,	therefore,	
progressive	course.	
Conclusions		
Thus,	 as	 a	 result	 of	 comparative	 study	 of	 clinical	 features	 of	 the	 disease,	 certain	
phenotypes	 of	 polypous	 rhinosinusitis	 were	 determined.	 It	 is	 characterized	 by	 the	 following	
indicators:	
-	Gender	 is	one	of	 the	most	 important	criteria	 that	determine	 the	phenotype.	Our	study	
clearly	 showed	 that	among	patients	with	 severe	polyposis	 females	prevailed	 -	58%	compared	 to	
other	types	of	polyposis.	
-	Age	 is	also	a	significant	criterion	 for	 the	 formation	of	pathological	phenotype.	Clinical	
pattern	of	the	disease	in	different	age	groups	had	its	peculiarities.	Most	patients	with	severe	forms	
of	polyposis	 (aspirin-intolerant	polyposis)	belonged	 to	 the	mature	age	group	-	36-70	years.	When	
the	onset	of	 the	disease	occurred	 in	childhood	or	adolescence	 then	we	could	observe	hereditary	
malformations	 (polyposis	 due	 to	 violations	 of	 aerodynamics	 of	 the	 nasal	 breathing)	 or	 Ig-E-
dependent	(allergic)	polyposis.	
-	Severity	of	the	disease.	Severity	of	clinical	course	of	polypous	rhinosinusitis	has	several	
features	 that	deserve	special	allocation	 into	phenotypic	marker.	The	severity	of	disease	 in	 these	
patients	is	associated	with	a	progressive,	relapsing	course	and	resistance	to	the	most	common	and	
effective	methods	of	treatment.	Although	severity	is	used	as	an	additional	criterion	for	phenotype	
allocation,	 its	 degree	 is	 often	 determined	 arbitrarily,	 but	 depends	 on	 age.	 Frequent	 recurrence,	
progressive	 course	 of	 the	 disease,	 especially	 in	 young	 people,	 regardless	 of	 gender,	 should	 be	
considered	as	a	severe	course.	These	severity	criteria	should	 include	 long	duration	of	the	disease	
that	along	with	recurrence	indicates	the	resistance	to	treatment.	
-	Nature	of	pathological	changes.	 In	patients	with	severe	 forms	of	polyposis	tendency	to	
pervasive	or	subtotal	lesions	of	the	sinuses	was	determined.	This	marker	is	particularly	important	
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in	 the	 onset	 of	 the	 diseases,	 especially	 at	 a	 young	 age,	 when	 clinical	 manifestations	 are	 often	
considered	as	symptoms	of	chronic	catarrhal	or	vasomotor	rhinosinusitis.		
	
Perspectives	for	further	research	
The	 possibility	 of	 forming	 phenotypic	 diagnostic	 features	 is	 promising	 as	 polypous	
rhinosinusitis	 is	 a	heterogeneous	disease,	 and	 the	phenotypes	mentioned	 above	 are	 considered	
within	clearly	defined	pathology.	The	recommendations	considering	different	markers	will	assist	
in	optimization	of	diagnostic	process	and	determination	of	adequate	therapeutic	tactics.	
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